Kevin Laliberte, Senior VP, Product Development at Dova Pharmaceuticals Inc. (DOVA), sold 3,696 shares at $28.00 ($103K) on 2019-09-30, disclosed to the SEC on 2019-10-02.
Open-market sale of $103k DOVA by Senior VP, Product Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.00 | 596 | $17K | 16.1% |
| 2 | $28.00 | 3,100 | $87K | 83.9% |
| Total | $28.00 avg | 3,696 | $103K | 100% |
| Filing → |
| DOVA | SELL | 2019-07-02 | $17K | — | Filing → |
| DOVA | BUY | 2017-07-07 | $105K | — | Filing → |